Antiviral activity against vesicular stomatitis virus infected in human HeLa cells assessed as inhibition of viral replication after 3 days by MTT assay
Antiviral activity against VSV psuedoparticles infected in human Huh7 cells assessed as inhibition of virus entry at 1 to 5 uM using Bright Glo reagent after 72 hrs by Luciferase reporter gene assay
Antiviral activity against Vesicular stomatitis virus ATCC VR 1540 infected in African green monkey Vero 76 cells assessed as reduction of virus-plaque formation after 2 days by crystal violet staining
Antiviral activity against Vesicular stomatitis virus G pseudoparticle infected in human Huh7.5.1 cells at 10 uM after 4 hrs by luciferase reporter gene assay
Antiviral activity against Vesicular stomatitis virus G pseudoparticle infected in human Huh7.5.1 cells at 3.2 uM after 4 hrs by luciferase reporter gene assay
Antiviral activity against Vesicular stomatitis virus G pseudoparticle infected in human Huh7.5.1 cells at 1 uM after 4 hrs by luciferase reporter gene assay
Antiviral activity against VSV infected in African green monkey Vero cells treated for 10 mins measured after 1 to 2 days by crystal violet staining-based assay
Antiviral activity against Vesicular stomatitis virus Indiana infected in Vero 76 cells after 2 days by crystal violet staining based plaque reduction assay
Effect on viral protein levels in recombinant Vesicular stomatitis virus-M40 expressing Ebola virus VP40 PPxY L-domain motif infected in HEK293T cells at 30 to 100 nM after 8 hrs by Western blot analysis relative to control